EP0711168A4 - Procedes de traitement de l'apoptose et d'etats associes - Google Patents
Procedes de traitement de l'apoptose et d'etats associesInfo
- Publication number
- EP0711168A4 EP0711168A4 EP94922680A EP94922680A EP0711168A4 EP 0711168 A4 EP0711168 A4 EP 0711168A4 EP 94922680 A EP94922680 A EP 94922680A EP 94922680 A EP94922680 A EP 94922680A EP 0711168 A4 EP0711168 A4 EP 0711168A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- associated conditions
- treating apoptosis
- apoptosis
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000006907 apoptotic process Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9678893A | 1993-07-23 | 1993-07-23 | |
US96788 | 1993-07-23 | ||
PCT/US1994/008268 WO1995003054A1 (fr) | 1993-07-23 | 1994-07-22 | Procedes de traitement de l'apoptose et d'etats associes |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0711168A1 EP0711168A1 (fr) | 1996-05-15 |
EP0711168A4 true EP0711168A4 (fr) | 1998-04-01 |
Family
ID=22259083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94922680A Withdrawn EP0711168A4 (fr) | 1993-07-23 | 1994-07-22 | Procedes de traitement de l'apoptose et d'etats associes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0711168A4 (fr) |
JP (1) | JPH09503749A (fr) |
KR (1) | KR960703597A (fr) |
AU (1) | AU7370594A (fr) |
BR (1) | BR9407145A (fr) |
CA (1) | CA2167805A1 (fr) |
WO (1) | WO1995003054A1 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3866800B2 (ja) | 1996-08-29 | 2007-01-10 | 東菱薬品工業株式会社 | アポトーシス関連疾患の予防及び/又は治療薬 |
WO2001019358A2 (fr) * | 1999-09-10 | 2001-03-22 | Cyathus Exquirere Pharmaforschungs Gmbh | Compositions pharmaceutiques destinees au traitement du psoriasis |
YU17002A (sh) | 1999-09-10 | 2004-11-25 | Cyathus Exquirere Pharmaforschungs Gmbh. | Upotreba deksrazoksana u lečenju psorijaze |
US6552025B1 (en) | 1999-11-24 | 2003-04-22 | Emory University | Diimino-piperazine derivatives for use as modulators of cell regulation |
WO2001037836A1 (fr) * | 1999-11-24 | 2001-05-31 | Emory University | Derives de la diimino-piperazine destines a etre utilises comme modulateurs de la regulation cellulaire |
AU7931301A (en) | 2000-08-04 | 2002-02-18 | Dmi Biosciences Inc | Method of using diketopiperazines and composition containing them |
CA3050734A1 (fr) | 2003-05-15 | 2004-12-02 | Ampio Pharmaceuticals, Inc. | Traitement de maladies a mediation des lymphocytes t |
GB0314733D0 (en) * | 2003-06-24 | 2003-07-30 | Glaxo Group Ltd | Medicaments |
US7838562B2 (en) * | 2003-06-24 | 2010-11-23 | University Of Connecticut | Methods of inhibiting vascular permeability and apoptosis |
WO2008021250A2 (fr) * | 2006-08-10 | 2008-02-21 | Fred Hutchinson Cancer Research Center | Compositions et procédés de modulation de l'apoptose dans des cellules surexprimant des protéines membres de la famille bcl-2 |
US8217047B2 (en) | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
WO2012033792A2 (fr) | 2010-09-07 | 2012-03-15 | Dmi Acquisition Corp. | Traitement de maladies |
US8980834B2 (en) | 2011-10-10 | 2015-03-17 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
KR20140075772A (ko) | 2011-10-10 | 2014-06-19 | 앰피오 파마슈티컬스 인코퍼레이티드 | 면역 내성을 증가시킨 이식 의료 장비, 및 그의 제조 및 이식 방법 |
SG11201400283RA (en) | 2011-10-28 | 2014-03-28 | Ampio Pharmaceuticals Inc | Treatment of rhinitis |
MX2015010937A (es) | 2013-03-15 | 2015-10-29 | Ampio Pharmaceuticals Inc | Composiciones para la movilizacion, autodireccion, expansion y diferenciacion de celulas madre y metodos para usar las mismas. |
JP6723222B2 (ja) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ,インコーポレイテッド | 関節病態の治療 |
WO2016209969A1 (fr) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Utilisation de fractions d'albumine de sérum humain de bas poids moléculaire pour traiter les maladies |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992008460A1 (fr) * | 1990-11-15 | 1992-05-29 | Windleshaw Enterprises Limited | Bis-dioxopiperazines pour traiter les tumeurs du foie |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8916072D0 (en) * | 1989-07-13 | 1989-08-31 | Creighton Andrew M | Pharmaceutical compositions |
-
1994
- 1994-07-22 JP JP7505327A patent/JPH09503749A/ja active Pending
- 1994-07-22 WO PCT/US1994/008268 patent/WO1995003054A1/fr not_active Application Discontinuation
- 1994-07-22 AU AU73705/94A patent/AU7370594A/en not_active Abandoned
- 1994-07-22 KR KR1019960700340A patent/KR960703597A/ko not_active Application Discontinuation
- 1994-07-22 CA CA002167805A patent/CA2167805A1/fr not_active Abandoned
- 1994-07-22 BR BR9407145A patent/BR9407145A/pt not_active Application Discontinuation
- 1994-07-22 EP EP94922680A patent/EP0711168A4/fr not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992008460A1 (fr) * | 1990-11-15 | 1992-05-29 | Windleshaw Enterprises Limited | Bis-dioxopiperazines pour traiter les tumeurs du foie |
Non-Patent Citations (12)
Also Published As
Publication number | Publication date |
---|---|
JPH09503749A (ja) | 1997-04-15 |
WO1995003054A1 (fr) | 1995-02-02 |
BR9407145A (pt) | 1996-09-17 |
EP0711168A1 (fr) | 1996-05-15 |
KR960703597A (ko) | 1996-08-31 |
AU7370594A (en) | 1995-02-20 |
CA2167805A1 (fr) | 1995-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA965088B (en) | Methods of preventing or treating allergles | |
ZA945426B (en) | Treatment of tachyarrhytmias of supraventricular origin | |
EP0711168A4 (fr) | Procedes de traitement de l'apoptose et d'etats associes | |
EP0586687A4 (en) | Trans-sialidase and methods of use and making thereof | |
GB9324773D0 (en) | Treatment of cellulose | |
ZA94338B (en) | Treatment of waste petroleum | |
HU9402361D0 (en) | New makrolides and use of them | |
PL301204A1 (en) | Method of obtaining avermectines and invermectines | |
GB9218027D0 (en) | Novel method of treatment | |
GB9202196D0 (en) | Method of treatment | |
EP0454169A3 (en) | Photomask and method of treating the same | |
ZA936166B (en) | Methods of treating cancer | |
GB9317943D0 (en) | Treatment of laminitis | |
GB9321679D0 (en) | Treatment of substrates | |
GB9201391D0 (en) | Method of treatment | |
EP0696055A3 (fr) | Assemblages électroniques et procédés de traitement | |
GB2265366B (en) | Treatment of waste | |
AU1033295A (en) | Methods of physical water treatment and apparatus therefor | |
EP0752856A4 (fr) | Procedes pour traiter l'hyperlipidemie | |
GB9408916D0 (en) | Treatment of sewage | |
EP0705104A4 (fr) | Therapie anticancereuse | |
GB9211484D0 (en) | Apparatus and method for the treatment of effluent | |
GB9314466D0 (en) | Methods of treating diamonds | |
GB9317989D0 (en) | Treatment of laminitis | |
GB9502689D0 (en) | Prevention and treatment of dementia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960214 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19980216 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19980426 |